Tumor-infiltrating lymphocytes: Potential and limitations to their use for cancer therapy
- 31 January 1992
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 12 (1) , 25-47
- https://doi.org/10.1016/1040-8428(92)90063-v
Abstract
No abstract availableThis publication has 94 references indexed in Scilit:
- Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumorsCancer Immunology, Immunotherapy, 1991
- Alteration in interactions between tumor-infiltrating lymphocytes and tumor cells in human melanomas after chemotherapy or immunotherapyCancer Immunology, Immunotherapy, 1991
- Preferential Localization of Human Adherent Lymphokine-Activated Killer Cells in Tumor MicrocirculationJNCI Journal of the National Cancer Institute, 1991
- Isolation, phenotyping, and functional analysis of lymphocytes from human liverClinical Immunology and Immunopathology, 1990
- Sustained outgrowth of autotumor-reactive T lymphocytes from human ovarian carcinomas in the presence of tumor necrosis factor α and interleukin 2Human Immunology, 1990
- Tumor-Infiltrating Lymphocytes and Interleukin-2 in MelanomasNew England Journal of Medicine, 1989
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Functional characterization of T lymphocytes propagated from human lung carcinomasClinical Immunology and Immunopathology, 1986
- Inhibition of Lymphocyte Proliferation by a Synthetic Peptide Homologous to Retroviral Envelope ProteinsScience, 1985